FDA's Norman Birenbaum Says There Really Is Not A Regulator In Place Right Now And That It Is Something That Is Appropriate And Is An Opportunity
Portfolio Pulse from Benzinga Newsdesk
Norman Birenbaum of the FDA has stated that there is currently no regulator in place for the cannabis industry, presenting an opportunity. The statement was made during a Benzinga Cannabis Capital Conference.
September 28, 2023 | 2:34 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
The lack of a regulator in the cannabis industry could impact MSOS, a cannabis-focused ETF, as regulatory changes can significantly affect the industry.
The lack of a regulator in the cannabis industry presents both risks and opportunities for MSOS. On one hand, it could lead to a lack of oversight and potential issues. On the other hand, it could also mean less restrictions and more growth potential. However, the introduction of a regulator could lead to significant changes in the industry, which could impact MSOS.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50